← Back to Clinical Trials
Recruiting NCT07888790

NCT07888790 Kinesio Taping in Young Adults With Thoracic Hyperkyphosis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07888790
Status Recruiting
Phase —
Sponsor Istinye University
Condition Thoracic Hyperkyphosis
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2026-10-20
Primary Completion 2026-12-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Kinesiology TapingSham Taping

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2026-10-20 with a primary completion date of 2026-12-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Thoracic hyperkyphosis is a postural disorder characterized by excessive thoracic curvature exceeding 40°, which may negatively affect proprioception, postural alignment, and muscle mechanical properties. Kinesiology taping (KT) has been proposed as a non-invasive intervention to improve postural control and proprioceptive feedback through cutaneous mechanoreceptor stimulation. However, evidence regarding its immediate effects on thoracic proprioception and muscle mechanical properties in young adults with thoracic hyperkyphosis remains limited. This sham-controlled randomized clinical trial aims to investigate the immediate effects of kinesiology taping on thoracic joint position sense, postural alignment, and muscle mechanical properties in young adults with thoracic hyperkyphosis. Muscle tone, stiffness, and elasticity will be assessed using MyotonPRO, alongside measurements of thoracic proprioception and postural alignment. The study will compare kinesiology taping with sham taping to determine whether kinesiology taping produces greater immediate improvements in these outcomes. The findings are expected to provide further evidence regarding the short-term sensorimotor and biomechanical effects of kinesiology taping in individuals with thoracic hyperkyphosis.

Eligibility Criteria

Inclusion Criteria: * Thoracic kyphosis angle (Cobb) on lateral radiograph: ≥40˚ - \<70˚ * Young adults aged 18-35 * Volunteering to participate in the study Exclusion Criteria: * Individuals with congenital or rigid deformities/anomalies in the spinal region * Individuals who have undergone major surgery or trauma related to the musculoskeletal system, particularly the spinal region * Individuals who have received physiotherapeutic intervention in the spinal region within the last 6 months * Individuals who use a corset * Body Mass Index (BMI) ≥ 30 * Those who have difficulty understanding the given commands * Those with systemic diseases (Diabetes, hypothyroidism, infection, malignancy...) * Those with neurological diseases * Those with rheumatic diseases in the active phase * Allergy to the tape material * Pregnancy

Contact & Investigator

Central Contact

Kubra Kardes, Asst. Prof.

✉ kubrakoce@gmail.com

📞 05387115631

Frequently Asked Questions

Who can join the NCT07888790 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Thoracic Hyperkyphosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07888790 currently recruiting?

Yes, NCT07888790 is actively recruiting participants. Contact the research team at kubrakoce@gmail.com for enrollment information.

Where is the NCT07888790 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07888790 clinical trial?

NCT07888790 is sponsored by Istinye University. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology